Skip to content
Clinical Trials – home
Norwegian University Of Science And Technolology
Sponsor

Norwegian University Of Science And Technolology

Norway Hoegskoleringen 1, 7034 Trondheim, Norway

About the sponsor

Clinical research includes treatment-focused studies in recurrent grade 3 and grade 4 glioma, with attention to therapeutic activity and tolerability in aggressive central nervous system tumours. The sponsor also supports work using PSMA theranostics in this setting.

  • Recurrent high-grade glioma
  • 177Lu-PSMA and 68Ga/177Lu-PSMA approaches
  • Safety and efficacy in brain tumour treatment

These activities reflect interest in advanced radioligand-based strategies for difficult-to-treat malignant brain disease.

About Specializations

Norwegian University Of Science And Technolology runs clinical trials in conditions such as Cluster headache, Small cell lung cancer limited stage, Dementia Alzheimer's type, Latent autoimmune diabetes in adults, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Norwegian University Of Science And Technolology
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Human Plasma Protein
  • Sponsor:Norwegian University Of Science And Technolology
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Glutamate Decarboxylase 2, Human, Recombinant
  • Sponsor:Norwegian University Of Science And Technolology
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Norwegian University Of Science And Technolology

Glioma

Not recruiting
Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177Lu) Zadavotide Guraxetan
  • Sponsor:Norwegian University Of Science And Technolology

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).